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The effect of  hydrocor t i sone  (HC) on PDGF #-recep- 
tor express ion  was  studied in the human mal ignant  me- 
so the l ioma cel l  l ine  Mero-14.  HC was  found to induce  a 
t ime-  and dose-dependent  increase  o f  PDGF #-receptor  
mRNA.  Nuc lear  run off ana lys i s  revea led  that  HC in- 
duced increased t ranscr ip t ion  of  the PDGF #-receptor  
gene.  The  express ion  of  PDGF #-receptor  prote in  was  
a lso e levated  by HC as demonst ra ted  w i th  an immuno-  
b lo t t ing  assay.  However ,  the number  of  PDGF-BB bind-  
ing  s i tes  on the cel l  sur face of  Mero -14  remained  un- 
changed upon HC t reatment .  These  resu l ts  suggest  hat  
s tero id  hormones  can regu late  PDGF receptor  expres-  
s ion  in v ivo.  9 1992 Academic Press, Inc. 
INTRODUCTION 
Platelet-derived growth factor (PDGF) is a mitogen 
for fibroblasts, mooth muscle cells, and glial cells and is 
composed of two disulfide-bonded polypeptides denoted 
PDGF A-chain and PDGF B-chain [1, 2]. Three possible 
isoforms of PDGF (AA, AB, and BB) have been identi- 
fied [3-5]. 
Two distinct PDGF receptors, designated PDGF a- 
and PDGF ft-receptor, were identified [6, 7] and found 
to dimerize upon binding of PDGF [8-10]. This can re- 
sult in three distinct PDGF receptor dimers (aa, aft, and 
ftft) with different specificities for PDGF: aa-receptors 
can be formed by all isoforms, aft-receptors by PDGF- 
AB and PDGF-BB, and #ft-receptors byPDGF-BB [10, 
11]. The PDGF a- and ft-receptors have been cloned and 
found to be encoded by two different genes mapped to 
human chromosomes 4 and 5, respectively [12-17]. 
The type of PDGF receptor that is expressed and the 
level of this expression could be the decisive factor in 
PDGF responsiveness. In several chronic inflammatory 
conditions like psoriasis, atherosclerosis, and rheuma- 
1 To whom correspondence and reprint requests should be ad- 
dressed at Department of Immunology, Erasmus University, P.O. 
Box 1738, 3000 DR Rotterdam, The Netherlands. Telefax: 31-10- 
436.7601. 
toid arthritis induction of PDGF ft-receptor expression 
was found on vascular and connective tissue cells [18- 
21]. The mechanism ofregulation of PDGF receptor ex- 
pression is still unknown. So far, few data are available 
on the regulation of PDGF receptor expression. Gron- 
wald et al. [22] found that TGF-ft decreased the number 
of PDGF a-receptors and increased the number of 
PDGF #-receptors in 3T3 cells. A TGF-ft-induced e- 
crease in PDGF a-receptor expression was also reported 
for human fibroblasts and smooth muscle cells [23]. In 
addition, PDGF itself induces the synthesis of the 
PDGF ft-receptor [24]. Embryonal carcinoma cells were 
found to increase the transcription of the PDGF a-re- 
ceptor gene upon exposure to retinoic acid with or with- 
out dibutyryl cyclic AMP [25]. Furthermore, it was re- 
cently suggested that the synergistic effect from combi- 
nations of cyclic AMP and growth factors on Schwann 
cells may be due to cyclic AMP-mediated induction of 
growth factor receptors [26]. 
Human malignant mesothelioma is a mesodermally 
derived tumor most frequently found in the pleura. Hu- 
man malignant mesothelioma cell lines were found to 
express PDGF #-receptors, whereas cultured normal 
mesothelial cells express predominantly PDGF a-re- 
ceptors [27]. Furthermore, xpression of PDGF A- and 
B-chain mRNA was found in malignant mesothelioma 
cell lines, while normal mesothelial cells expressed 
PDGF A-chains and had a barely detectable l vel of 
PDGF B-chain mRNA [28, 29]. 
In this paper we describe a time- and dose-dependent 
increase of PDGF ft-receptor mRNA expression upon 
addition of hydrocortisone (HC) to the culture medium 
of the malignant mesothelioma cell line Mero-14. In ad- 
dition, we studied whether the PDGF ft-receptor mRNA 
induction was due to increased transcription or differ- 
ences in RNA stability. Immunoblotting and binding 
experiments with 125I-PDGF were performed to investi- 
gate the effect of HC on the protein level. 
MATERIALS AND METHODS 
Cell lines and growth conditions. The isolation of normal and ma- 
lignant mesothelial cell lines and the characteristics of Mero-14 were  
described earlier [30, 31]. 
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Cells were cultured in F10 medium with 15% fetal calf serum 
(FCS), 0.1 mg/ml streptomycin sulfate (Biochrom KG, Berlin, Ger- 
many), and 100 IU/ml penicillin G sodium (Gist-Brocades, Delft, The 
Netherlands). The medium was supplemented with 10 ng/ml epider- 
mal growth factor (EGF; Collaborative Research, Lexington, MA) 
and/or 0.1, 0.2, 0.4, 0.8, or 1.6 ttg/ml hydrocortisone (Pharma Chemie, 
Haarlem, The Netherlands) when indicated. 
RNA isolation and Northern blot analysis. RNA isolation and 
Northern blot analysis were performed as described [29]. The filters 
were washed at 42~ to 0.3• SSC and exposed to a Fuji-RX film. 
Probes. The PDGF a-receptor probe was a 1.5-kb EcoR1 frag- 
ment [13] and the PDGF fi-receptor probe was a 1-kb Pstl  fragment 
[12]. These fragments correspond to the extracellular domain of the 
PDGF a- and PDGF ~-receptors, respectively. The GAPDH probe 
was a 0.7-kb EcoR1-Pstl fragment [32]. 
PDGF, radiolabeled ligands, and radioreceptor assay. PDGF-AA 
and PDGF-BB were recombinant material expressed in yeast and 
were 125I-labeled by the chloramine T and Bolton and Hunter meth- 
ods, respectively, to specific activities of 80,000 (PDGF-AA) and 
50,000 (PDGF-BB) cpm/ng [33]. 
For the radioreceptor assay, cells were plated in 12-well plates 
(Costar, Cambridge, MA). When confluence was reached, the cells 
were washed with phosphate buffered saline (PBS) and incubated for 
24 h in serum-free F10 medium at 37~ Prior to binding, the cells 
were washed with 1 ml PBS supplemented with bovine serum albu- 
min (BSA; Boehringer, Mannheim, Germany), 1mg/ml. Binding was 
performed for 2 h at 0~ in a volume of 350 #1 PBS-BSA containing 
50,000 cpm radiolabeled ligands with or without unlabeled PDGF 
(250 ng/ml). After three washes with ice-cold PBS-BSA the cells 
were lysed in 2% Triton X-100 in H20. 125I-Radioactivity was counted 
in a gamma counter. 
Nuclear run off assay. Nuclei were isolated from 108 cells essen- 
tially according to Zenke t al. [34] with the presence of 0.5% NP-40 in 
the lysis buffer as the only modification. From each cell line 1-2 • 107 
nuclei were used for a nuclear un off analysis, as adapted from Linial 
et al. [35]. The ultimate concentration f Tris-HCl, pH 8.0, in the run 
off buffer was 6 mM, while 140 #Ci [a-~2p]UTP was added. Synthesis 
of transcripts took place at 30~ for 20 min followed by treatment 
with 10 #g DNase ! for 5 min at 30~ After centrifugation, the nu- 
clear RNA pellet was resuspended in a buffer containing 45% (v/v) 
formamide, 0.2 M NaP i (pH 7.2), 1 mM EDTA, 7% SDS, and 250 
#g/ml yeast RNA. 
Plasmid DNA was spotted on nitrocellulose filters with the 
Schleicher and Schuell slot blot apparatus (S & S, Dassel, Germany) 
and immobilized for 2 h at 80~ Subsequently, the filters were hybrid- 
ized with the labeled RNA for 2 days at 45~ After hybridization, 
filters were washed for 8 h at 65~ in 40 m/~ NaP i (pH 7.2), 1% SDS 
interrupted by washing in 2• SSC containing RNaseA (5 #g/ml) for 
30 min at 37~ Autoradiography was performed at -80~ with Ko- 
dak XAR films. 
Immunoblotting. Mero-14 cells were cultured until confluence 
was nearly reached either without HC or with the addition of 0.4 or 
0.8 #g/ml HC. Cells were washed with PBS and harvested in PBS 
with 0.02% NaEDTA. For each lane 2 • 106 cells were lysed in a buffer 
containing 0.5% Triton X-100, 0.5% deoxycholate, 25mM Tris-HC1, 
pH 7.5, 150 mM NaC1, 10 mM EDTA, and protease inhibitors. After 
centrifugation, the lysate was incubated with wheat germ lectin Seph- 
arose 6 MB (WGA; Pharmacia, Uppsala, Sweden) on an end-over- 
end rotator overnight at 4~ After washing with lysis buffer the 
beads were boiled for 5 min in sample buffer containing 2.5% SDS. 
The proteins were separated on a 8% SDS-polyacrylamide g l and 
blotted to nitrocellulose. Subsequently, the filter was washed twice in 
PBS blocked in skim milk and washed three times in PBS, containing 
0.2% Tween. The filter was incubated 2 h at room temperature in 
1:100 diluted PDGFR-3, which recognizes PDGF ~-receptors [36]. 
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FIG. 1. Northern blot analysis of25 #g total RNA from the malig- 
nant mesothelioma cell lines Mero-14 and Mero-82. These cell lines 
were cultured for 24 h in medium with 15% FCS and supplemented 
with EGF (10 ng/ml), EGF (10 ng/ml) plus HC (0.4 #g/ml), or HC (0.4 
ttg/ml) only. The filter was hybridized to a 32P-labeled PDGF fi-recep- 
tor probe and a GAPDH probe. 
After washing, goat anti-rabbit-IgG-alkaline phosphatase (Tago, 
Burlingame, CA) was used as a second step. 
Growth kinetics. Triplicate cultures were started in 12-well plates 
(25 • 103 cells/culture). After 24 h the medium was changed to F10 
medium with 15% FCS and 0.4 ttg/ml HC or F10 medium with FCS 
only. Two days later, the cells were harvested by trypsinization and 
the number of cells was counted. 
RESULTS 
Effect of Hydrocortisone on PDGF ~-Receptor mRNA 
According to Connell and Rheinwald [37] normal me- 
sothelial cells have an optimal growth in medium supple- 
mented with EGF and HC. For our experiments con- 
cerning PDGF receptor expression, ormal mesothelial 
cells were cultured in medium supplemented withEGF 
and HC, whereas the malignant mesothelioma cell lines 
did not require the addition of EGF and HC. In order to 
investigate whether addition of these upplements af- 
fected the PDGF receptor expression i normal and ma- 
lignant mesothelial cells, seven malignant mesotheli- 
oma cell lines were cultured with EGF and HC and nor- 
mal mesothelial cells without. No difference in the 
pattern of PDGF receptor expression of normal and ma- 
lignant cells was observed, except for Mero-14. This ma- 
lignant mesothelioma cell line was found to increase the 
level of PDGF fl-receptor mRNA expression upon addi- 
tion of EGF and HC to the culture medium (Fig. 1). The 
effect of EGF only and HC only on PDGF ~-receptor 
expression in Mero-14 was tudied and compared with 
the malignant mesothelioma cell line Mero-82. These 
cell lines were cultured for 24 h in F10 medium with 15% 
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FIG. 2. Northern blot analysis of 25 #g total RNA of Mero-14 
cells incubated with HC (0.4 #g/ml) for 3, 6, 24, or 48 h. The filter was 
hybridized to a ~2P-labeled PDGF j3-receptor probe and a GAPDH 
probe. 
FIG. 3. Northern blot analysis of 25 #g total RNA of Mero-14 
cells incubated for 24 h with various HC concentrations (0.1, 0.2, 0.4, 
and 0.8 gg/ml). The filter was hybridized to a a2P-labeled PDGF B-re- 
ceptor probe and a GAPDH probe. 
FCS and supplemented with EGF, EGF  plus HC, or HC 
only. After harvesting, RNA was isolated and analyzed 
for PDGF fl-receptor RNA expression. Mero-14 showed 
an increase in PDGF ~-receptor mRNA upon the addi- 
t ion of EGF  plus HC or HC only (Fig. 1). Addition of 
EGF  only to Mero-14 cells resulted in a similar level of 
PDGF ~-receptor mRNA expression as F10 medium 
without supplementat ion (Fig. 1). Mero-82 was used as 
a control  and did not exhibit a change in PDGF/3-recep- 
tor RNA expression upon addition of EGF  and/or  HC to 
the culture medium (Fig. 1). 
To determine the t ime dependence of the increase of 
PDGF fl-receptor mRNA expression in Mero-14, 
mRNA was prepared from cells incubated with HC for 
3, 6, 24, or 48 h. HC caused an increase of PDGF/3-re-  
ceptor mRNA in Mero-14, which was clearly detectable 
f rom 24 h after incubation with HC and was even more 
pronounced after 48 h (Fig. 2). 
Nor thern  blot analysis of mRNA from Mero-14 incu- 
bated with various concentrat ions of HC revealed a 
dose-dependent increase in PDGF ~-receptor mRNA 
expression from 0.1 to 0.8 #g/ml HC (Fig. 3). In addition 
to HC, dexamethasone was found to increase the PDGF 
/3-receptor mRNA expression in Mero-14 (data not 
shown). Hybridizat ion of a filter with mRNA from 
Mero-14 and several other mal ignant  mesothel ioma cell 
lines with a probe for the glucocorticoid receptor re- 
vealed the presence of mRNA for this receptor in Mero- 
14 as well as in other mal ignant  mesothel ioma cell lines 
at approximately  similar levels (data not shown). 
In order to investigate whether  the observed HC- in-  
duced increase of PDGF fl-receptor mRNA was due to 
an increased rate of transcr ipt ion or a difference in cy- 
toplasmic degradation, uclear run off analysis was per- 
formed. Nuclear RNA levels of PDGF A- and B-chain 
and PDGF a- and fi-receptor in HC- t reated  Mero-14 
cells were compared with those in untreated Mero-14 
cells (Fig. 4). The quality and expression of the PDGF 
receptor RNA was related to the constitutively ex- 
pressed actin gene and pUC was used to exclude the 
possibil ity that  the observed signal was due to cross hy- 
bridization with vector sequences. These exper iments  
revealed that  HC- t reated  Mero-14 cells had an elevated 
level of nuclear PDGF fl-receptor RNA compared to 
that  of untreated Mero-14 cells. The PDGF a-receptor  
mRNA remained undetectable in HC- t reated  and un- 
t reated Mero-14 cells. 
Effect of HC on PDGF ~-Receptor Protein 
To investigate whether  the observed increase in 
PDGF fi-receptor mRNA upon HC addit ion results in
an elevation of the amount  of PDGF ~-receptor protein, 
addit ion of  HC - -I- 
pUC - 
actin - 
PDGF-B - 
PDGF-A - 
G-receptor - 
/3-receptor - 
FIG. 4. Nuclear un off analysis of s2P-labeled nuclear RNA of 
Mero-14 cells cultured with or without HC. The radiolabeled tran- 
scripts were hybridized to the plasmids pUC, pUC + actin, pUC + 
PDGF-B, pUC + PDGF-A, pUC + PDGF a-receptor, and pUC + 
PDGF B-receptor. 
86 VERSNEL ET AL. 
kD 
206 - 
180 ---- 
100 - 
68-  
concentration HC (pg/ml) 
0 0 0.4 0.8 
,-- 180 
I I 
cell l ine NM-1 Mero-14 
FIG. 5. Detection of PDGF 3-receptors by immunoblotting with 
the antibody PDGFR-3 in Mero-14 cells cultured for 24 h without HC 
or with 0.4 or 0.8/~g/ml HC. As a control the PDGF 3-receptor nega- 
tive normal mesothelial cell line NM-1 was used. 
immunoblotting and radioreceptor assays were per- 
formed. 
For immunoblotting, Mero-14 cells were incubated 
for 24 h either without HC or with 0.4 or 0.8 ug/ml HC. 
The normal mesothelial line NM-1 which has no detect- 
able PDGF 3-receptors was used as a control. After lysis 
and incubation with WGA-Sepharose, the glycopro- 
tein-enriched lysate was separated by electrophoresis 
and blotted. The filter was incubated with the PDGF 
3-receptor specific antiserum PDGFR-3. As a control, 
lanes were incubated with normal rabbit serum and 
PBS. In all three samples of Mero-14 cells, a PDGF 
3-receptor specific band of 180 kDa was detected. This 
band increased in intensity upon the addition of in- 
creasing amounts of HC prior to lysis, showing the most 
pronounced band when Mero-14 cells were incubated 
with 0.8 #g/ml HC (Fig. 5). Control anes did not reveal 
a PDGF 3-receptor specific band. These data indicate 
that HC increases not only PDGF 3-receptor mRNA 
but also PDGF 3-receptor protein synthesis n Mero-14. 
The level of membrane-associated PDGF fl-receptors 
in Mero-14 and Mero-82 cells cultured with and without 
HC was compared using a radioreceptor assay with 125I- 
labeled PDGF-AA and 125I-labeled PDGF-BB. The bind- 
ing of 125I-labeled PDGF-AA to Mero-14 and Mero-82 
cultured without HC was not significantly over the 
background. 125I-labeled PDGF-BB was found to have a 
specific binding to Mero-14 and Mero-82, which was 
lower in the presence of unlabeled PDGF-BB (Fig. 6). 
These results are in agreement with earlier experiments 
with a panel of malignant mesothelioma cell lines [27]. 
Addition of 0.4/~g/ml HC to Mero-14 and Mero-82 24 
h prior to binding experiments did not reveal an in- 
crease in the specific binding of either 125I-labeled 
PDGF-AA or 125I-labeled PDGF-BB compared to cells 
cultured without HC. These results uggest that the in- 
crease in synthesis of PDGF 3-receptor protein expres- 
sion after 24 h HC treatment does not result in a net 
increased cell surface expression of PDGF 3-receptors. 
An alternative possibility is that HC causes also a de- 
crease in receptor affinity. This has not been excluded. 
Proliferation of Malignant Mesothelioma Cell Lines in 
the Presence of HC 
We investigated whether the addition of HC also af- 
fected the proliferation of malignant mesothelioma cell 
lines. Four malignant mesothelioma cell lines were 
grown in the presence of 0.4 #g/ml HC for 48 and 72 h, 
followed by counting of the cell numbers. The prolifera- 
tion of all four investigated malignant mesothelioma 
cell lines (Mero-14, -41, -48b, and -82) was found to be 
inhibited compared to cells grown without HC. The per- 
centage inhibition after 48 and 72 h varied between 20 
and 31 (Table 1). 
DISCUSSION 
This paper shows that HC enhances the PDGF fl-re- 
ceptor mRNA and protein synthesis in the human malig- 
nant mesothelioma cell line Mero-14 in a time- and 
dose-dependent manner. Nuclear run off analysis re- 
vealed that the HC-induced effect on PDGF 3-receptor 
mRNA expression was due to an increased transcrip- 
tion rate of the PDGF 3-receptor gene. In contrast, 
PDGF a-receptor mRNA was undetectable with or 
without HC addition. 
In a previous paper we described expression of the 
PDGF A- and B-chain genes in a panel of malignant 
mesothelioma cell lines including Mero-14 [32]. These 
cell lines were found to express PDGF 3-receptors [25]. 
Coexpression of PDGF B-chain and PDGF 3-receptors 
is thus common in malignant mesothelioma cell lines 
and suggests that autocrine growth stimulation i volv- 
ing PDGF may be important in the transformation pro- 
cess. In the case of the Mero-14 cell line, HC stimulation 
might thus, under certain conditions, potentiate an au- 
tocrine loop, by stimulation of PDGF 3-receptor synthe- 
sis. HC treatment did not affect the PDGF B-chain 
mRNA expression i  Mero-14 cells (data not shown). 
The effect of HC on PDGF 3-receptor expression in 
Mero-14 was detected on the mRNA and protein level, 
whereas no increase of membrane bound receptors was 
found in the receptor binding assay. It should be noted, 
however, that the amount of PDGF receptors at the cell 
surface is dependent on the balance between synthesis 
and degradation of receptors. In Mero-14 cells, the deg- 
radation is likely to be accelerated by the endogenous 
production of PDGF, which is likely to induce an in- 
creased internalization and degradation of receptors: 
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FIG. 6. Binding of 125I-PDGF-AA (open bars) and 125I-PDGF-BB (stippled bars) in the absence (-) or presence (+) of unlabeled ligand to 
Mero-14 cells cultured for 24 h without (-) or with HC (+) (0.4 #g/ml). 
whether the degradation rate is affected by HC treat-  
ment  remains to be determined. 
Glucocorticoids have been shown to st imulate or in- 
hibit cell prol i feration in a variety of cell culture sys- 
tems. We demonstrated that  HC inhibited the growth of 
four human mal ignant mesothel ioma cell lines includ- 
ing Mero-14. The mechanism for inhibition remains to 
be elucidated. Clearly, however, HC affects growth of 
Mero-14 cells in more than one way; whereas the induc- 
t ion of PDGF fl-receptors would be expected to stimu- 
late growth, the net effect during the in vitro conditions 
studied in this communicat ion is growth inhibition. 
HC is a glucocorticoid that, upon binding to the glu- 
cocorticoid receptor, regulates transcr ipt ion of genes 
that  have a glucocorticoid responsive lement (GRE) 
[38]. Since the promoter  egion of the PDGF ~-receptor 
gene has not yet been characterized, it is not known 
TABLE 1 
Inhibition of the Proliferation of Malignant Mesothelioma 
Cell Lines upon Addition of HC to the Culture Medium 
Culture period 
Cell line 48 h a (%) 72 h a (%) 
Mero-14 22 25 
Mero-41 25 30 
Mero-48b 31 20 
Mero-82 28 30 
a At 48 and 72 h after addition of HC the cells were harvested and 
counted. Data presented are the mean of two independent experi- 
ments. 
whether it contains a GRE. I t  was suggested earlier by 
Terracio et al. [39] that  the observed expression of 
PDGF ~-receptor on cells of the endometr ium ay be 
steroid hormone dependent.  Although it cannot  be ex- 
cluded that  the effect of HC is directly on PDGF-~ re- 
ceptor transcript ion, an indirect effect seems more 
likely. This is supported by the observat ion that  24 h 
HC t reatment  is necessary for a detectable increase in 
PDGF ~-receptor mRNA,  which is rather  long for a di- 
rect effect of HC on PDGF-/~ receptor gene expression. 
For the insulin receptor, for instance, it has been de- 
scribed that  HC can induce an increase in specific re- 
ceptor mRNA within 2 h [40]. Furthermore,  it was re- 
cently reported by Wang et al. [25] that  embryonal  carci- 
noma cells after retinoic acid addition increase their 
PDGF a-receptor  RNA expression within 4 h [25]. 
F rom seven investigated mal ignant  mesothel ioma 
cell lines only Mero-14 showed increased PDGF/~-re-  
ceptor expression upon culturing in medium supple- 
mented with HC. I t  is unclear why of seven investigated 
mal ignant  mesothel ioma cell lines that  all express 
PDGF /~- and glucocorticoid receptors, only Mero-14 
cells increased their PDGF fl-receptor expression upon 
HC addition. This may suggest hat  a cofactor is in- 
volved which is act ivated in Mero-14 cells only. All ma- 
l ignant mesothel ioma cell lines have abnormal  karyo- 
types with multiple numerical  and structural  abnormal i -  
ties [30, 31]. Compar ison of the karyotype of Mero-14 
with the other mal ignant  cell lines did not reveal an 
aberrat ion that  could be involved in the HC- induced 
PDGF/~-receptor  expression. 
In conclusion, we have demonstrated that  HC induces 
an increase of PDGF fl-receptor mRNA and protein in 
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the mal ignant  mesothe l ioma cell l ine Mero-14.  Th is  in- 
crease was found to be due to an  e levated t ranscr ip t ion  
of the PDGF H-receptor gene. Our  resul ts  suggest hat  
regulat ion of PDGF receptor  express ion in vivo may be 
el ic i tated by steroid hormones .  
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